Literature DB >> 16280766

Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma.

Bin K Kroon1, Renato A Valdés Olmos, Harm van Tinteren, Omgo E Nieweg, Simon Horenblas.   

Abstract

PURPOSE: We evaluated the reproducibility of lymphoscintigraphy in the assessment of the location and number of sentinel nodes in patients with penile carcinoma.
MATERIALS AND METHODS: A total of 20 patients were prospectively included in analysis. Lymphoscintigraphy was performed after intradermal injection of technetium nanocolloid around the tumor or excision scar. We performed 10-minute anterior dynamic imaging, and static anterior and lateral images were obtained at 30 minutes and 2 hours. The following day scintigraphy was repeated after a second injection of the radiolabeled colloid given in an identical fashion, preceded by acquisition of a starting image. An observer evaluated the paired images and count rates were calculated from the images.
RESULTS: At least 1 sentinel node was visualized in all patients on the first lymphoscintigram. A total of 56 sentinel nodes were seen in 38 basins. Drainage to both groins was seen in 18 patients. In 1 of these patients drainage to the prepubic area was also observed. There were 2 patients with drainage to 1 groin. The second lymphoscintigram revealed the same drainage pattern in all patients- the same number of nodal basins and number of sentinel nodes were visualized at identical locations. All hotspots that were visualized during the first lymphoscintigram showed an unequivocal increase in radioactivity after repeat injection. Thus, the reproducibility of penile lymphoscintigraphy was 100% (95% CI 85%-100%). The Pearson correlation coefficient of the paired count rates was 0.69 (p <0.0001).
CONCLUSIONS: Results of lymphoscintigraphy in patients with penile carcinoma are highly reproducible for assessment of the number and location of sentinel nodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280766     DOI: 10.1097/01.ju.0000181813.43631.e5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 2.  Contemporary inguinal lymph node dissection: minimizing complications.

Authors:  Philippe E Spiess; Mike S Hernandez; Curtis A Pettaway
Journal:  World J Urol       Date:  2008-09-02       Impact factor: 4.226

3.  Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:  Peter E Clark; Philippe E Spiess; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

Review 4.  Metastatic penile carcinoma - an update on the current diagnosis and treatment options.

Authors:  Dimitri Barski; Evangelos Georgas; Holger Gerullis; Thorsten Ecke
Journal:  Cent European J Urol       Date:  2014-06-23

Review 5.  Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?

Authors:  O R Brouwer; H G van der Poel; R F Bevers; E J van Gennep; S Horenblas
Journal:  Clin Transl Imaging       Date:  2016-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.